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Background: The excess and persistent accumulation of fibroblasts due to aberrant tissue repair results in fibrotic
diseases such as idiopathic pulmonary fibrosis. Recent reports have revealed significant changes in microRNAs
during idiopathic pulmonary fibrosis and evidence in support of a role for microRNAs in myofibroblast
differentiation and the epithelial-mesenchymal transition in the context of fibrosis. It has been reported that
microRNA-21 is up-regulated in myofibroblasts during fibrosis and promotes transforming growth factor-beta
signaling by inhibiting Smad7. However, expression changes in microRNA-21 and the role of microRNA-21 in
epithelial-mesenchymal transition during lung fibrosis have not yet been defined.
Methods: Lungs from saline- or bleomycin-treated C57BL/6 J mice and lung specimens from patients with
idiopathic pulmonary fibrosis were analyzed. Enzymatic digestions were performed to isolate single lung cells. Lung
epithelial cells were isolated by flow cytometric cell sorting. The expression of microRNA-21 was analyzed using
both quantitative PCR and in situ hybridization. To induce epithelial-mesenchymal transition in culture, isolated
mouse lung alveolar type II cells were cultured on fibronectin-coated chamber slides in the presence of
transforming growth factor-β, thus generating conditions that enhance epithelial-mesenchymal transition. To
investigate the role of microRNA-21 in epithelial-mesenchymal transition, we transfected cells with a microRNA-21
inhibitor. Total RNA was isolated from the freshly isolated and cultured cells. MicroRNA-21, as well as mRNAs
of genes that are markers of alveolar epithelial or mesenchymal cell differentiation, were quantified using
quantitative PCR.
Results: The lung epithelial cells isolated from the bleomycin-induced lung fibrosis model system had decreased
expression of epithelial marker genes, whereas the expression of mesenchymal marker genes was increased.
MicroRNA-21 was significantly upregulated in isolated lung epithelial cells during bleomycin-induced lung fibrosis
and human idiopathic pulmonary fibrosis. MicroRNA-21 was also upregulated in the cultured alveolar epithelial cells
under the conditions that enhance epithelial-mesenchymal transition. Exogenous administration of a microRNA-21
inhibitor prevented the increased expression of vimentin and alpha-smooth muscle actin in cultured primary
mouse alveolar type II cells under culture conditions that induce epithelial-mesenchymal transition.
Conclusions: Our experiments demonstrate that microRNA-21 is increased in lung epithelial cells during lung
fibrosis and that it promotes epithelial-mesenchymal transition.
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In normal tissue repair, collagen deposition after inflam-
mation or injury is an indispensable and reversible reac-
tion for wound healing. However, if the tissue injury is
massive or repetitive and/or if the repair process itself
becomes abnormal and the excessive and persistent ac-
cumulation of myofibroblasts and extracellular matrix
proteins, including collagen, has occurred, the result
is a fibrotic disease such as idiopathic pulmonary fi-
brosis (IPF).
MicroRNAs are non-coding RNA molecules that con-
sist of 22 nucleotides and function in the transcriptional
and post-transcriptional regulation of gene expression
[1]. Recent reports have revealed significant changes in
microRNAs during both lung fibrosis and human fi-
brotic lung disease. Moreover, accumulating evidence
suggests a role for microRNAs in myofibroblast diffe-
rentiation and the endothelial-mesenchymal transition
(EMT) in the context of lung fibrosis. let-7d, which is
abundantly expressed in epithelial cells in normal lungs,
is down-regulated in the lung tissues of IPF patients [2].
The expression of let-7d is inhibited by transforming
growth factor-β (TGF-β) [2], and the downregulation of
let-7d promotes EMT in epithelial cells and increased
collagen deposition in mouse lungs [2]. The microRNA-
200 (miR-200) family can reverse EMT and induce an
epithelial phenotype in cancer cells [3-8]. The miR-200
family targets the ZEB factors (ZEB1 and ZEB2) that
function as transcriptional repressors. Because ZEB fac-
tors induce EMT by suppressing the expression of epi-
thelial marker genes, including E-cadherin [9,10], the
overexpression of miR-200 s decreases expression of
ZEB factors and induces epithelial differentiation. A
recent publication showed that the miR-200 family
members inhibit TGF-β-induced EMT in a rat alveolar
epithelial cell line [11].
MicroRNA-21 (miR-21) was first identified as an anti-
apoptotic factor in glioblastomas [12] and has been
described as an oncogenic microRNA targeting many
tumor suppressor genes, including PTEN [13]. Recently,
it has been shown that miR-21 has a role in lung fibrosis.
miR-21 is increased in the whole lung of bleomycin-
instilled mice [14] as well as in lung biopsy samples of
IPF patients [14-16]. miR-21 is induced by TGF-β1 and
targets the inhibitory Smad, Smad7 [14]. Thus, miR-21
amplifies TGF-β signaling in a positive feedback fashion.
Because TGF-β signaling can induce and maintain EMT,
we postulated that miR-21 could contribute to EMT in
lung epithelial cells during lung fibrosis, though a previ-
ous report showed that increased miR-21 expression was
primarily localized to myofibroblasts [14].
To investigate the roles of miR-21 in EMT of lung al-
veolar epithelial cells during lung fibrosis, we first exa-
mined the miR-21 expression changes in lung epithelialcells during bleomycin-induced lung fibrosis. Because
lungs consist of various types of cells and because ex-
pression patterns of molecules, including microRNAs,
differ among these cell types, we developed a flow-
cytometric cell sorting method for isolating mouse lung
epithelial cells from cells such as mesenchymal and
endothelial cells. We also examined changes in the ex-
pression of these microRNAs in cultured primary mouse
lung alveolar type II epithelial cells under EMT-inducing
conditions. In addition, to elucidate the role of miR-21
in EMT, we examined whether inhibition of miR-21
attenuated EMT induced by TGF-β in primary mouse
alveolar type II cells.
Methods
Animal studies
All animal experiments were approved by the Tohoku
University Animal Experiment Ethics Committee and
were performed in accordance with the Regulations for
Animal Experiments and Related Activities at Tohoku
University.
Patients and preparation of tissue samples
Human lung tissue was obtained from patients who
underwent lung resections at the Department of Tho-
racic Surgery at Tohoku University Hospital (Aobaku,
Sendai, Japan) or at Ishinomaki Red Cross Hospital
(Hebita, Ishinomaki, Japan). Non-fibrotic lung tissue
specimens were obtained from 3 patients who under-
went surgery for lung cancer. The specimens were re-
sected from portions distal to the cancerous lesions, and
histopathological examination confirmed that these non-
fibrotic tissues did not contain any lesions, including
those associated with cancer, fibrosis, emphysema or in-
flammatory changes. Fibrotic lung tissue specimens were
obtained from 3 patients who underwent open lung
biopsy or lung resection because of lung cancer. The pa-
tients were clinically diagnosed as having IPF based on
pathological examinations of the fibrotic lesions. This
study was approved by the Ethics Committees at Tohoku
University School of Medicine and the Ishinomaki Red
Cross Hospital. All subjects gave informed consent.
The animal model of pulmonary fibrosis
Seven- to eight-week-old male C57BL/6 mice were used
in our experiments. C57BL/6 mice were purchased from
CLEA Japan (Yokohama, Japan). All mice were housed
in a specific pathogen-free facility and were maintained
under constant temperature (24°C), humidity (40%), and
light cycle (8:00 A.M. to 8:00 P.M.) conditions, with food
and water provided ad libitum. To induce pulmonary fi-
brosis, mice were treated intratracheally with bleomycin
hydrochloride (Nippon Kayaku, Tokyo, Japan) on day 0
as described in our previous study [17]. Briefly, mice
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jection and were then instilled with 0.04 mg of bleo-
mycin hydrochloride in 100 μl of saline through a 27G
needle inserted between the cartilaginous rings of the
trachea. The lungs were harvested 14 days after instilla-
tion for further analyses.The preparation of single lung cells from whole lung
Single lung cells from mice were isolated as previously
described with some modifications [18]. Briefly, mice re-
ceived an overdose of inhaled halothane, and their lungs
were perfused with PBS via the right ventricles. The
PBS-perfused lungs were isolated with other mediastinal
organs. The Dispase II solution (Roche Applied Science,
Mannheim, Germany; final concentration, 2.0 U/mL)
was instilled into the lungs through the trachea, which
was then ligated with a silk suture. After incubation at
37°C for 50 min, the lungs were separated from the
other mediastinal organs. The lungs were then thor-
oughly minced and digested in PBS containing 0.1%
collagenase (Roche Applied Science) and 0.01% de-
oxyribonuclease I (Sigma-Aldrich, St. Luis, MO) at
37°C for 20 min. The cells were then suspended in
red blood cell lysis buffer to remove red blood cells
(Sigma-Aldrich) and were subsequently washed with
PBS. The cells were then centrifuged and re-suspended
in PBS.Flow cytometry and the sorting of lung component cells
We used the following antibodies: Alexa Fluor 647-
conjugated anti-mouse EpCAM antibody (clone G8.8,
Biolegend, San Diego, CA); phycoerythrin (PE)-conju-
gated anti-mouse VE-cadherin antibody (clone VECD1,
Biolegend); and fluorescein isothiocyanate (FITC)-con-
jugated anti-mouse CD45 antibody (clone 30-F11,
Biolegend). To discriminate between live and dead cells,
we used 7-amino actinomycin D (7-AAD; eBioscience,
San Diego, CA). The antibodies were incubated with
the samples for 30 min at 4°C and the samples were
then washed. We re-suspended the cells in 2% FBS/
PBS and labeled dead cells with 7-AAD. We sorted
live and single-cell-gated subpopulations based on
their staining patterns using EpCAM, VE-cadherin
and CD45 with a FACS Aria II Cell Sorter and FACS
Diva ver 6.1 (BD Biosciences, San Jose, CA). FACS
analyses were conducted using FCS Express 3 soft-
ware (De Novo Software, Los Angeles, CA). The
sorted epithelial (CD45-, EpCAM+ cells), endothelial
(CD45-, VE-cadherin+ cells) and mesenchymal cells
(CD45-, EpCAM-, VE-cadherin- cells) were collected
in DMEM/10% FCS/Penicillin/Streptomycin/amphote-
ricin B (Life Technologies, Grand Island, NY) for fur-
ther analyses.Isolation of alveolar epithelial type II cells from human
lung tissues
Human lung cells were isolated as previously described
[19], and human ATII cells were isolated as previously
described with some modifications [20]. Briefly, we used
phycoerythrin-conjugated anti-human EpCAM antibody,
Alexa Fluor 647-conjugated anti-human T1α antibody,
and FITC-conjugated anti-human VE-cadherin antibody.
To discriminate between live and dead cells, we used 7-
amino actinomycin D. We sorted live and single-cell-
gated subpopulations based on their staining patterns
for EpCAM, T1α, and VE-cadherin expression using a
FACS Aria II Cell Sorter and FACS Diva, version 6.1
(BD Biosciences).
Total RNA purification and the quantification of
microRNAs and mRNAs
Total RNA containing microRNAs was purified from the
cells using the miRNeasy Mini Kit (Qiagen, Hilden,
Germany). A miScript Reverse Transcription Kit was used
for reverse transcription of microRNAs and mRNAs into
cDNA. The microRNAs were quantified by real-time PCR
using an miScript Primer Assay (Qiagen). mRNAs were
also quantified by real-time PCR using a QuantiTect
Primer Assay (Qiagen). The specific primer sets for
quantification were purchased from Qiagen as follows:
MS00001827 for miR-200c; MS00011487 for miR-21;
MS00033740 for RNU6B snRNA (a constitutively ex-
pressed housekeeping control); QT00121163 for E-
cadherin; QT00109424 for Surfactant protein C (SP-C);
QT00110467 for VE-cadherin; QT00159670 for Vi-
mentin; QT00140119 for alpha-smooth muscle actin
(α-SMA); QT00105385 for ZEB1; QT00148995 for ZEB2
(E-cadherin repressors); QT01658692 for glyceraldehyde-
3-phosphate dehydrogenase (GAPDH, a constitutively
expressed gene).
In situ hybridization (ISH)
In situ hybridization was performed according to manu-
facturer’s protocol provided in the MicroRNA ISH Buf-
fer and Controls Kit (Exiqon, Woburn, MA), with some
modifications. Briefly, human lung tissues were inflated
with 10% formalin solution and embedded in paraffin.
Mouse lung tissues were inflated with 4% paraformal-
dehyde solution and embedded in paraffin. Slides were
deparaffinized and incubated with proteinase-K for
10 min at 37°C and washed with PBS. The hybridization
mixture contained 5 nM double-DIG LNA™ microRNA
probe for miR-21 or scramble-miR as the negative con-
trol (Exiqon) and was applied and hybridized for 1 h at
53°C. Slides were washed in SSC buffer and incubated
with RNase solution (20 μg/ml, Wako Pure Chemical
Industries, Osaka, Japan) for 30 min at 37°C. Slides were
washed in SSC buffers and incubated with blocking
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anti-digoxigenin-POD (poly) Fab fragments (at 1:500 in
antibody diluent, Roche) were applied and incubated
overnight at 4°C. Slides were then washed and incu-
bated with biotin-SP-conjugated AffiniPure goat anti-
horseradish peroxidase (1:200) at 37°C for 30 min
(Jackson ImmunoResearch). Finally, the slides were
washed and labeled with Streptavidin-AP (Roche).
NBT/BCIP solution (Roche) was used for detection.
After washing in water and counter-staining with Nuclear
Fast Red, the slides were dehydrated and mounted for
observation by microscopy.
The isolation and culture of murine alveolar type II cells
Murine alveolar type II cells were prepared from 7-
week-old male C57BL/6 mice by a modification of the
method of Corti et al. [21]. Mice were anesthetized with
a ketamine-xylazine-atropine mixture by intraperitoneal
injection. The abdominal cavity was opened, and mice
were exsanguinated by cutting the inferior vena cava
and the left renal artery. The diaphragm was cut, and
the chest plate and thymus were removed. With the use
of a 23G needle on a 10-ml syringe, the lungs were per-
fused with 10 ml of 0.9% saline via a right ventricle. The
trachea was isolated and cannulated with a 20-gauge iv
catheter that was secured by a ligature. Two ml BD
Dispase solution (BD Bioscience) was rapidly instilled
through the cannula into the trachea followed by 0.5 ml
low melting point agarose (Sigma-Aldrich) that was
preheated to 45°C. The lungs were immediately covered
with ice for 2 min to allow the agarose to solidify. After
this incubation, the lungs were removed from the
animals and incubated in 1 ml BD dispase for 45 min
(25°C) before being placed on ice until the next step.
The lungs were subsequently transferred to a 100 mm
culture dish containing 10 ml of 25 mM HEPES-
buffered DMEM/10% FCS/Penicillin/Streptomycin/am-
photericin B (Life Technologies) and 100 U/ml DNase I
(Sigma-Aldrich). The lung tissue was gently teased from
the bronchi by curved forceps and was then gently
swirled for 10 min. The resulting cell suspension was
filtered sequentially through 100 μm and 40 μm cell
strainers (BD Biosciences). The single lung cells were
collected by centrifugation at 1200 rpm for 10 min at
4°C. The cells were re-suspended in PBS with 0.5% BSA
and 2 mM EDTA and were then incubated with MACS
Mouse CD45 MicroBeads (Miltenyi Biotec, Bergisch
Gladbach, Germany) for 15 min at 4°C. The cells were
then washed before proceeding to magnetic separation
by autoMACS (Miltenyi Biotec) to deplete CD45+ cells.
The collected CD45- cells were then incubated with
an anti-FITC-conjugated anti-mouse EpCAM antibody
(Biolegend) for 10 min at 4°C. After washing, the cells were
incubated with MACS anti-FITC MicroBeads (MiltenyiBiotec) for 15 min at 4°C. After incubation and washing,
the cells were separated magnetically by autoMACS
(Miltenyi Biotec) to collect the CD45- EpCAM+ cells. The
collected cells were assessed by immunostaining for
EpCAM and pro SP-C. Greater than 99% of the cells were
positive for EpCAM and >96% of cells were typically
positive for pro-SP-C. Viability was >95%.
The cells were cultured on chamber slides that were
coated with Matrigel-rat tail collagen (70:30 vol/vol) to
maintain the mouse type II cell phenotype in vitro [22]
or were cultured in human fibronectin pre-coated cham-
ber slides (BD Biosciences) under EMT-inducing culture
conditions. The cells were maintained in SAGM (Lonza,
Basel, Switzerland) without hydrocortisone and contai-
ning 5% charcoal/dextran-treated FBS (Invitrogen,
Carlsbad, CA) and 10 ng/ml human recombinant KGF
(Rocky Hill, NJ) in a 37°C, 5% CO2 incubator as described.
For the EMT-inducing culture conditions, 4 ng/ml human
recombinant TGF-β was added to the media. The cells
were analyzed on culture day 6.
The transfection of microRNA mimics and/or inhibitors
into murine alveolar type II cells
We transfected synthesized miR-200c (Qiagen) and/or a
miR-21 inhibitor composed of single-stranded, modified
RNAs that specifically inhibit miR-21 function (miScript
miRNA Inhibitor; Qiagen) into isolated mouse alveolar
type II cells using HiPerFect Transfection Reagent
(Qiagen). Control oligonucleotides (Qiagen) were trans-
fected into negative control samples. To optimize trans-
fection conditions, we used AllStars Hs Cell Death
Control siRNA (Qiagen), which targets essential cell sur-
vival genes. The transfection efficiency was measured by
observation of the level of cell death after the transfec-
tion of this siRNA. The transfection conditions that
resulted in more than 80% cell death when compared
with transfection with control oligonucleotides was used
in the experiments. After transfection, the alveolar type
II cells were cultured on fibronectin-coated chamber
slides with SAGM supplemented with 5% charcoal/dex-
tran-treated FBS, 10 ng/ml KGF and 4 ng/ml TGF-β,
conditions that enhance EMT. The transfections of the
microRNA and/or the miR-21 inhibitor were repeated
on day 3. The cells were harvested on day 6.
Data presentation and statistical analysis
Unless otherwise noted, all data presented are expressed
as the means ± standard error of the means (SEM). Stat-
istical analyses were performed using Statistica software
(StatSoft Inc., Tulsa, OK, USA). The data were assessed
for significance using an unpaired t-test for comparisons
between the two groups or by ANOVA with Scheffé’s
post hoc method for multiple comparisons. Statistical
significance was defined as p < 0.05.
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The identification and isolation of epithelial, endothelial
and mesenchymal cells from mouse lungs
To investigate the levels of expression of miR-21 in lung
epithelial cells precisely, we utilized flow cytometric cell























































































































































Figure 1 The identification and isolation of epithelial, endothelial and
cell sorting strategy. Single lung cells were stained with antibodies against
exclusion. Epithelial, endothelial and mesenchymal cells are identified as CD
CD45- EpCAM- VE-cadherin- cells, respectively. (B) The expression of mRNA
(En) cells from untreated mice. The mean and SEM of relative mRNA expre
are presented for E-cadherin and SPC. For VE-cadherin, values relative to th
values relative to those of mesenchymal cells are presented. The data were
(Scheffé’s test). * p < 0.05 versus lung epithelial cells. † p < 0.05 versus lungand mesenchymal cells (Figure 1A). A lung cell suspen-
sion was prepared by enzymatic digestion. We first ex-
cluded CD45+ cells and dead cells by staining with both
an anti-CD45 antibody and 7-AAD. Then, CD45- cells
were analyzed for surface expression of both EpCAM

















































































mesenchymal cells from mouse lungs. (A) A fluorescence-activated
EpCAM, VE-cadherin and CD45. 7-AAD was used for dead cell
45- EpCAM+ VE-cadherin- cells, CD45- EpCAM- VE-cadherin+ cells and
s in isolated lung epithelial (Ep), mesenchymal (Me) and endothelial
ssion are shown (n = 6). The values relative to those of epithelial cells
ose of endothelial cells are presented. For vimentin, ZEB1 and ZEB2,
analyzed by one-way analysis of variance with a post hoc test
mesenchymal cells.
Yamada et al. Respiratory Research 2013, 14:95 Page 6 of 13
http://respiratory-research.com/content/14/1/95(a specific marker for endothelial cells). We identified and
isolated three cell populations: CD45- EpCAM+ VE-
cadherin- cells as epithelial cells; CD45- EpCAM- VE-
cadherin+ cells as endothelial cells; and mesenchymal cells
as CD45- EpCAM- VE-cadherin- cells. The expression of
mRNAs of marker genes was examined in these isolated
lung cell populations (Figure 1B). E-cadherin (a specific
marker for epithelial cells) and surfactant protein-C
(SFTPC, a marker for alveolar type II cells) were specific-
ally expressed in isolated lung epithelial cells, whereas VE-
cadherin mRNA (a specific marker for endothelial cells)





























































































































































Figure 2 miR-21 is increased in lung epithelial cells during experimen
cytometric analyses of CD45- lung cells from saline- and bleomycin-treated
Note that bleomycin induced a decrease in the percentage of epithelial ce
change in endothelial cells (En). (C) The relative expression of mRNA of lun
(Vimentin, Zeb1 and Zeb2) is shown. (D) The relative expression of microRN
those of the saline-treated epithelial cells are presented. The data were ana
group. † p < 0.05 between saline group and bleomycin group in each cell(a marker for mesenchymal cells) and ZEB1/2 (EMT
inducers) were very low when compared to the levels
of these markers in lung mesenchymal cells. These data
suggested that isolated CD45- EpCAM+ VE-cadherin- cells
obviously had an epithelial cell phenotype.
miR-21 increases in lung epithelial cells during
experimental bleomycin-induced lung injury
To investigate the expression levels of miR-21 in lung
epithelial cells during lung fibrosis, we used the mouse
model of bleomycin-induced lung fibrosis. Flow cytome-










































tal bleomycin-induced lung injury. (A) Representative flow
mice. (B) The percentage of each cell type within all CD45- lung cells.
lls (Ep) and an increase in that of mesenchymal cells (Me) but no
g epithelial marker genes (E-cadherin and SFTPC) or EMT marker genes
As is shown. The values are mean ± SEM (n = 6). The values relative to
lyzed by Student t test. * p < 0.05 versus epithelial cells in the saline
type. § p < 0.05 versus epithelial cells in the bleomycin group.
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centage of mesenchymal cells in isolated lung CD45- cells,
suggesting that fibrotic changes had occurred in the lungs
of bleomycin-treated mice (Figure 2A and 2B). The level
of E-cadherin mRNA was significantly decreased in lung
epithelial cells that were isolated from bleomycin-treated
mice (Figure 2C). SFTPC was also decreased. However,
vimentin and ZEB 1/2 were significantly increased in lung
epithelial cells that were isolated from bleomycin-treated
mice (Figure 2C). These observations implied that epi-
thelial-mesenchymal transition in lung epithelial cellsFigure 3 Histological analyses for miR-21 expression in mouse and hu
hybridization for miR-21 was performed in mouse lung tissues obtained fro
show the areas demonstrating severe and mild fibrotic lesions, respectively
minimal background staining (B). (E-G) In situ hybridization for miR-21 was p
fibrotic lung disease (E) and patients with IPF (F, G). Figure 3F and 3G show t
Arrows indicate staining for miR-21. Asterisks indicate fibrotic foci. Arrowheadhad occurred during experimental bleomycin-induced
lung injury.
Next, we examined the changes in expression levels of
miR-21 in isolated epithelial, endothelial and mesenchy-
mal cells from lungs treated with saline or bleomycin. In
the saline treated mice, miR-21 was expressed in all lung
cell populations, but the level of miR-21 in lung epithe-
lial cells was significantly higher compared with that in
endothelial or mesenchymal cells. The bleomycin treat-
ment increased miR-21 significantly in all lung cell pop-
ulations and the levels of miR-21 were also significantlyman lung tissues using in situ hybridization. (A-D) In situ
m saline- (A) or bleomycin-treated mice (C, D). Figure 3C and 3D
. Staining using control probes with a scrambled sequence showed
erformed in non-fibrotic lung tissue obtained from patients without
he areas demonstrating severe and mild fibrotic lesions, respectively.
s indicate anthracosis. Bar = 50 μm.
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cells including mesenchymal cells. This result is contrary
to previous reports showing that myofibroblasts were
the main source of the increased miR-21 levels present
in bleomycin-treated lungs (Figure 2D). These observa-
tions suggest that miR-21 may also participate in EMT
of lung epithelial cells. We also examined the levels of
miR-200c, one of the miR-200 family microRNAs that
are expressed in the cells, preserve epithelial phenotypes
and function as EMT suppressors. The levels of miR-
200c were much higher in lung epithelial cells than in
endothelial or mesenchymal cells in saline treated mice
(Figure 2D). In contrast to miR-21, miR-200c decreased
significantly in epithelial cells, implying that miR-200c
also functions as an EMT suppressor in lung epithelial
cells (Figure 2D).
We also performed in situ hybridization for miR-21 in
lung tissues from saline- or bleomycin-treated mice, and
we observed scattered staining for miR-21 in the alveoli
of saline-treated mouse lungs (Figure 3A). In particular,
the morphology of the stained cells seemed to be com-
patible with that of alveolar type II cells (Figure 3A). As
a control, background staining using control probes with
a scrambled sequence was very weak (Figure 3B). In
bleomycin-treated mice, staining for miR-21 was ob-
served in cells surrounding fibrotic foci but not in cells
within fibrotic foci (Figure 3C). Furthermore, increased
staining for miR-21was observed in alveoli from areas
showing milder fibrotic changes (Figure 3D), and the
morphology of these stained cells was similar to that of
alveolar type II cells (Figure 3D).
miR-21 is increased in lung epithelial cells from patients
with IPF
Our data showed that miR-21 expression is increased in












 Alveolar type II cells
(CD45-, VE-cadherin-, EpCAM+, T1-α-)
Figure 4 miR-21 is increased in lung alveolar type II cells from idiopa
cytometric analyses of CD45- VE-cadherin- lung cells for the isolation of hu
the non-fibrotic lungs of patients without fibrotic lung diseases and the fib
is shown. The values represent the mean ± SEM (n = 3). The values relative to
presented. The data were analyzed with Student’s t-test. * p < 0.05 versus thefibrosis. Therefore, we further examined the expression
levels of miR-21 in the lungs of patients with IPF com-
pared to that in non-fibrotic lungs. In situ hybridization
for miR-21 showed scattered staining for miR-21 in the
alveolar cells of non-fibrotic lung tissue (Figure 3E). In
IPF lung tissues, staining for miR-21 was observed in
cells surrounding fibrotic foci, but not in cells within fi-
brotic foci (Figure 3F). Staining for miR-21 was also ob-
served in alveoli located in areas showing milder fibrotic
changes (Figure 3G).
To investigate the changes in miR-21 expression in hu-
man lung epithelial cells from patients with IPF more pre-
cisely, we isolated alveolar type II cells from human lung
specimens by flow cytometric cell sorting (Figure 4A)
[20]. miR-21 expression was significantly higher in alveo-
lar type II cells isolated from the lungs of IPF patients than
in those present in non-fibrotic lungs (Figure 4B). In con-
trast, the levels of miR-200c were decreased significantly
in alveolar type II cells from IPF patients (Figure 4B).
The culture conditions that induce EMT by TGF-β
up-regulated the expression of miR-21 in cultured
alveolar epithelial cells
We observed an increase of miR-21 in isolated lung
epithelial cells in which EMT occurred in vivo during
bleomycin-induced lung injury. To clarify whether cul-
ture condition that induce EMT also increased miR-21
in alveolar epithelial type II cells cultured in vitro, we
cultured mouse alveolar epithelial type II cells and in-
duced EMT using endogenous and exogenous TGF-β as
previously reported [23,24]. For cultured mouse alveolar
type II cells, lung cell suspensions were prepared by
intratracheal instillation of Dispase and agarose, followed
by mechanical disaggregation of the lungs according to
the method of Corti et al. [21]. CD45+ cells were de-





































































thic pulmonary fibrosis (IPF) patients. (A) Representative flow
man alveolar type II cells (CD45- VE-cadherin- EpCAM+ T1-α- cells) from
rotic lungs of patients with IPF. (B) The relative expression of microRNAs
those of the human alveolar type II cells from non-fibrotic lungs are
non-fibrotic lung group.
Yamada et al. Respiratory Research 2013, 14:95 Page 9 of 13
http://respiratory-research.com/content/14/1/95for using a magnetic beads-based cell sorting instead of
flow cytometric cell sorting because of the high number
of isolated cells required for in vitro culture experiments.Figure 5 The EMT-inducing culture conditions increase miR-21 expres
cytometric analyses for the expression of pro-SFTPC in isolated mouse alve
both EpCAM and pro-SFTPC. (B) Representative immunofluorescence stain
positive for pro-SFTPC (left), whereas EPCAM-CD45- cells were negative for
conditions (EMT; cultured on fibronectin with TGF-β for 6 days) decrease lu
gene expression in mouse lung alveolar epithelial cells. The relative express
SFTPC) or EMT marker genes (vimentin, α-SMA, Zeb1 and Zeb2) is shown. T
observed prior to culture. The data were analyzed by one-way analysis of v
cultured (NC). † p < 0.05 versus control cultures (Con; cultured on Matrigel/
shown. The values are mean ± SEM (n = 6). microRNA expression was relati
one-way analysis of variance with a post hoc test (Scheffé’s test). * p < 0.05We isolated 3.0 ± 0.5 million cells per mouse and >96%
of the isolated cells were positive for pro-SFTPC as shown
by intracellular immunostaining (Figure 5A) as well as bysion in mouse lung alveolar epithelial cells. (A) Representative flow
olar type 2 cells. Note that most of the isolated cells were positive for
ing for pro-SFTPC in the isolated cells. Most of the isolated cells were
pro-SFTPC (right). Scale bars: 20 μm. (C) The EMT-inducing culture
ng epithelial cell marker gene expression and increase EMT marker
ion of mRNA of lung epithelial cell marker genes (E-cadherin and
he values are mean ± SEM (n = 6). mRNA is expressed relative to levels
ariance with a post hoc test (Scheffé’s test). * p < 0.05 versus cells not
collagen for 6 days). (D) The relative expression of microRNAs is
ve to the levels observed prior to culture. The data were analyzed by
versus NC. † p < 0.05 versus Con.
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http://respiratory-research.com/content/14/1/95flow cytometric analyses (Figure 5B), indicating that the
purity of the isolated alveolar type II cells is acceptable for
in vitro culture experiments. The control culture condi-
tions that can maintain the mouse type II cell phenotype
in vitro [22] did not change the levels of expressions of
mRNAs of E-cadherin, SFTPC, vimentin, α-SMA or
ZEB1/2 when compared with those in freshly isolated
alveolar type II cells (Figure 5C). The expression of
E-cadherin and SFTPC decreased in alveolar type II
cells cultured under EMT-inducing conditions, whereas
the expression of vimentin, α-SMA and ZEB1/2 increased,
suggesting that EMT had occurred in the cultured alveolar


































































































Figure 6 miR-21 attenuates TGF-β-induced epithelial-mesenchymal tr
mRNA of lung epithelial cell marker genes (E-cadherin and SFTPC) or EMT
6 days after culture in the condition inducing EMT is shown. The values are
prior to culture. NC: cells not cultured. MOCK: cells only treated with transfe
miR-200c: cells transfected with synthesized miR-200c. miR-21-i: cells transfe
with both synthesized miR-200c and miR-21-i. The data were analyzed by o
* p < 0.05 versus NC. † p < 0.05 versus MOCK. § p < 0.05 versus Con siRNA.We then examined the expression changes of miR-21
in cultured alveolar type II cells. The control culture
conditions did not influence the expression of miR-21.
The culture conditions that induced EMT by TGF-β sig-
nificantly increased miR-21 expression in alveolar epi-
thelial type II cells when compared with the freshly
isolated cells and the cells cultured under the control
conditions (Figure 5D). In contrast to miR-21, the EMT
inducing culture conditions decreased the expression of
miR-200c (Figure 5D). These observations indicated that
miR-21 increased in pulmonary epithelial cells both



































































































ansition in mouse alveolar type II cells. The relative expression of
marker genes (vimentin, α-SMA, Zeb1 and Zeb2) prior to culture or
mean ± SEM (n = 6). mRNA is expressed relative to levels observed
ction reagents. Con siRNA: cells transfected with non-targeting siRNA.
cted with miR-21 inhibitor. miR-200c & miR-21-i: cells co-transfected
ne-way analysis of variance with a post hoc test (Scheffé’s test).
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http://respiratory-research.com/content/14/1/95The inhibition of miR-21 attenuates TGF-β-induced
epithelial-mesenchymal transition in mouse alveolar type
II cells
Our in vivo and in vitro experiments showed that miR-21
was upregulated in mouse lung epithelial cells during
EMT. To clarify the contribution of miR-21 to EMT of
lung alveolar epithelial cells, we examined whether the in-
hibition of miR-21attenuated EMT induced by TGF-β in
primary mouse alveolar type II cells. A miR-21 inhibitor
composed of single-stranded, modified RNAs that spe-
cifically inhibit miR-21 function was transfected into the
cultured alveolar type II cells. We also transfected non-
specific oligonucleotides as negative controls or syn-
thesized miR-200c as positive controls because miR-200c
has been reported to be an EMT suppressor. The transfec-
tion of synthesized miR-200c significantly attenuated the
increased expression of vimentin and α-SMA as well as
that of Zeb1/2 and prevented the decrease in E-cadherin
expression in cultured mouse alveolar type II cells that
was induced by the pro-EMT environment containing
TGF-β (Figure 6). The miR-21 inhibitor also prevented ex-
pression of vimentin, α-SMA and ZEB1/2 but did not
modify E-cadherin expression significantly, though we did
observe the tendency of miR-21 to prevent the decrease in
E-cadherin expression (Figure 6). Neither synthesized
miR-200c nor the miR-21 inhibitor prevented the decrease
in SFTPC expression. Transfection of both miR-200c and
the miR-21 inhibitor had no significant added effect
on the down-regulation of mesenchymal cell markers
(Figure 6). Phase contrast images of cultured mouse
alveolar type II cells showed that cells cultured underFigure 7 Representative phase contrast images of mouse alveolar typ
cells 6 days after culture are shown. MOCK: cells only treated with transfect
miR-200c: cells transfected with synthesized miR-200c. miR-21-i: cells transfe
synthesized miR-200c and miR-21 inhibitor. Note that the cells cultured un
irregular processes, whereas cells transfected with synthesized miR-200c an
granules (lamellar bodies). Scale bars: 20 μm.EMT-inducing conditions adopted a spindle-like shape
with irregular processes, whereas cells transfected with
miR-21 inhibitor as well as synthesized miR-200c adopted
a cobblestone-like appearance and had lamellar body-like
granules (Figure 7). These data showed that inhibition of
miR-21 attenuated EMT induced by TGF-β in cultured
primary mouse alveolar type II cells, suggesting the contri-
bution of miR-21 to EMT in lung epithelial cells
Discussion
Our study first demonstrated that miR-21 is up-regulated
in isolated lung epithelial cells during bleomycin-induced
lung injury as well as in cultured lung epithelial cells
under EMT-inducing conditions. Inhibiting miR-21 pre-
vented the EMT induced in cultured primary mouse al-
veolar type II cells, suggesting that miR-21 promotes EMT
of lung epithelial cells.
Previous reports showed that miR-21 is increased in
whole lung samples both in bleomycin-induced mouse
models of lung fibrosis and in human patients with IPF
[14-16,25]. The examinations by in situ hybridization
and immunohistochemistry showed that myofibroblasts
were the main source of the increased miR-21 levels
during bleomycin-induced lung fibrosis [14,16]. miR-21
targets an inhibitory smad, SMAD7 and administration
of miR-21 antisense probes attenuated the severity of
bleomycin-induced fibrosis by blocking the positive feed-
back loop of TGF-β signaling [14]. The biological func-
tions of miR-21 have also attracted the attention of
researchers in various fields, including oncology. miR-21
is significantly upregulated in human cancer of variouse II cells cultured under EMT-inducing conditions. Images of the
ion reagents. Con siRNA: cells transfected with non-targeting siRNA.
cted with miR-21 inhibitor. 200c & 21-i: cells co-transfected with both
der EMT-inducing conditions adopted their spindle-like shape with
d/or miR-21 inhibitor adopted a cobblestone-like appearance and had
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http://respiratory-research.com/content/14/1/95organs [13]. miR-21 targets the genes related to cell cycle
control, apoptosis and invasion; thus, this microRNA be-
haves as an oncogenic factor [13]. Because most cancer
cells are derived from epithelial cells in various tissues in-
cluding lung, we hypothesized that miR-21 was also
expressed and had a role in EMT of lung epithelial cells
by promoting TGF-β signaling during lung fibrosis. We
observed that miR-21 was expressed more in epithelial
cells when compared with mesenchymal cells and endo-
thelial cells in mouse lungs and increased miR-21 expres-
sion was observed in lung epithelial cells in the lungs
of mice with bleomycin-induced fibrosis as well as
the lungs of patients with IPF. Inhibition of miR-21
prevents the increase of mesenchymal markers and
ZEB factors in cultured lung alveolar epithelial cells
under the EMT-inducing conditions promoted by TGF-β.
Our findings suggested that miR-21 works as a potential
inducer of EMT in lung epithelial cells by promoting
TGF-β signaling.
In situ hybridization revealed that miR-21 was upre-
gulated in the fibrotic lungs of both mouse and human,
as previously reported [14,25]. However, we observed
that miR-21 was expressed in alveolar cells morphologic-
ally resembling alveolar type II cells in the normal lung.
In addition, miR-21 expression was increased in cells
surrounding fibrotic foci, rather than in the fibrotic foci
themselves, during lung fibrosis, which is in contrast to
previously published data showing by in situ hybri-
dization and immunostaining that miR-21 is mainly
expressed in myofibroblasts [14,25]. We developed a
flow-cytometric cell sorting method for isolating epithe-
lial, mesenchymal and endothelial cells from mouse and
human lung tissue [26], because the expression patterns
of molecules, including microRNAs, differ between cell
types. These data showed that each isolated cell type
expressed a specific set of gene markers and that miR-21
was more highly expressed in lung epithelial cells than
in mesenchymal cells, in agreement with our in situ
hybridization data. Therefore, we believe that we have
carefully analyzed the expression of miR-21 in each lung
cell type, including epithelial cells, and that our results
reveal that miR-21 is expressed most prominently in
lung epithelial cells. In contrast, previous reports did not
perform precise analyses in specific cell types using ex-
pression analyses of whole lung samples, in situ hy-
bridization and immunostaining. Similar to our report of
the method for isolating cellular components from
human lung tissue [26], techniques that can isolate
specific cell types in the lung are useful for investigating
the specific roles of a variety of molecules, including
microRNAs, in specific cells under both physiological
and pathological conditions.
The signaling pathways that are activated by transfor-
ming growth factor-β (TGF-β) are involved in promotingEMT [9,10,27]. TGF-β signaling induces the expression of
transcription factors such as ZEB1, ZEB2, slug and snail,
which negatively regulate the expression of E-cadherin
and activate genes of mesenchymal markers such as
vimentin and α-smooth muscle actin (α-SMA). Therefore,
it is likely that microRNAs, including let-7d, miR-21 and
miR200c, that are involved in TGF-β signaling also play a
significant role in EMT during lung fibrosis [2,11,14].
It has also been reported that epithelial cells are
potential sources of myofibroblasts via the epithelial-
mesenchymal transition (EMT) in renal [28,29], hepatic
[30,31] and lung fibrosis [23,24]. In contrast, a recent
study using mouse genetic tools to track the fates of
lung epithelial cells showed that both alveolar type II
cells and Scgb1a1-positive lung cells are not a major
source of myofibroblasts through EMT [32], suggesting
that EMT does not directly contribute to lung fibrosis
in vivo. Although the in vivo inhibition of miR-21 pre-
vents bleomycin-induced lung fibrosis in mice [14], it
remains debatable whether the inhibition of EMT im-
proves or worsens the pathological condition of lung
fibrosis.
Conclusions
In summary, we demonstrated that miR-21 is increased
mainly in lung epithelial cells in a mouse model of lung
fibrosis as well as in isolated alveolar type II cells cul-
tured under EMT-inducing conditions. Inhibiting the
function of miR-21 resulted in the prevention of EMT
induced by TGF-β. Taken together, our data suggest that
miR-21 promotes EMT in lung epithelial cells during
lung fibrosis.
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